Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce J Brew

Showing results (91-100 of 180) with videos related to

Pageof 18
Sort By:
AIDS (London, England)|January 31, 2016
Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorderThomas M Gates, Lucette A Cysique, Krista J Siefried, et al.
AIDS Research and Human Retroviruses|February 16, 2006
Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usageMeet Shah, Theresa K Smit, Susan Morgello, et al.
Journal of Neurology|April 11, 2007
CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegenerationSahra Abdulle, Asa Mellgren, Bruce J Brew, et al.
AIDS and Behavior|October 7, 2020
Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic ReviewHtein Linn Aung, Maral Aghvinian, Hetta Gouse, et al.
Neuropharmacology|June 7, 2016
Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosisJong-Min Lee, Vanessa Tan, David Lovejoy, et al.
AIDS Research and Therapy|June 8, 2010
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infectionLars Hagberg, Paola Cinque, Magnus Gisslen, et al.
Journal of Neurovirology|June 5, 2013
A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomesDavid B Clifford, Avindra Nath, Paola Cinque, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2020
Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIVMaëliss Calon, Kritika Menon, Andrew Carr, et al.
Advances in Experimental Medicine and Biology|June 23, 2004
Quinolinic acid in the pathogenesis of Alzheimer's diseaseGilles J Guillemin, Kieran R Williams, Danielle G Smith, et al.
BMC Neurology|December 23, 2021
Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infectionBirgitta Anesten, Henrik Zetterberg, Staffan Nilsson, et al.
Pageof 18

Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
AIDS (London, England)|January 31, 2016
Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorderThomas M Gates, Lucette A Cysique, Krista J Siefried, et al.
AIDS Research and Human Retroviruses|February 16, 2006
Env gp120 sequence analysis of HIV type 1 strains from diverse areas of the brain shows preponderance of CCR5 usageMeet Shah, Theresa K Smit, Susan Morgello, et al.
Journal of Neurology|April 11, 2007
CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegenerationSahra Abdulle, Asa Mellgren, Bruce J Brew, et al.
AIDS and Behavior|October 7, 2020
Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic ReviewHtein Linn Aung, Maral Aghvinian, Hetta Gouse, et al.
Neuropharmacology|June 7, 2016
Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosisJong-Min Lee, Vanessa Tan, David Lovejoy, et al.
AIDS Research and Therapy|June 8, 2010
Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infectionLars Hagberg, Paola Cinque, Magnus Gisslen, et al.
Journal of Neurovirology|June 5, 2013
A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomesDavid B Clifford, Avindra Nath, Paola Cinque, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2020
Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIVMaëliss Calon, Kritika Menon, Andrew Carr, et al.
Advances in Experimental Medicine and Biology|June 23, 2004
Quinolinic acid in the pathogenesis of Alzheimer's diseaseGilles J Guillemin, Kieran R Williams, Danielle G Smith, et al.
BMC Neurology|December 23, 2021
Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infectionBirgitta Anesten, Henrik Zetterberg, Staffan Nilsson, et al.
Pageof 18